BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seo KS, Kim JH, Min KN, Moon JA, Roh TC, Lee MJ, Lee KW, Min JE, Lee YM. KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts. Front Neurol 2018;9:552. [PMID: 30026729 DOI: 10.3389/fneur.2018.00552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim YY, Um JH, Shin DJ, Jeong DJ, Hong YB, Yun J. p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells. FASEB J 2021;35:e21319. [PMID: 33433933 DOI: 10.1096/fj.202002007R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Manolis AS, Manolis AA, Manolis TA, Apostolaki NE, Apostolopoulos EJ, Melita H, Katsiki N. Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications. Med Res Rev 2021;41:275-313. [PMID: 32959403 DOI: 10.1002/med.21732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Smeitink J, van Maanen R, de Boer L, Ruiterkamp G, Renkema H. A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms ("KHENERGYC"). BMC Neurol 2022;22:158. [PMID: 35477351 DOI: 10.1186/s12883-022-02685-3] [Reference Citation Analysis]
4 Kobayashi H, Hatakeyama H, Nishimura H, Yokota M, Suzuki S, Tomabechi Y, Shirouzu M, Osada H, Mimaki M, Goto YI, Yoshida M. Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations. Nat Chem Biol 2021;17:335-43. [PMID: 33168978 DOI: 10.1038/s41589-020-00676-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ma C, Xia F, Kelley SO. Mitochondrial Targeting of Probes and Therapeutics to the Powerhouse of the Cell. Bioconjug Chem 2020;31:2650-67. [PMID: 33191743 DOI: 10.1021/acs.bioconjchem.0c00470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Weissig V. Drug Development for the Therapy of Mitochondrial Diseases. Trends Mol Med 2020;26:40-57. [PMID: 31727544 DOI: 10.1016/j.molmed.2019.09.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
7 Almannai M, El-Hattab AW, Ali M, Soler-Alfonso C, Scaglia F. Clinical trials in mitochondrial disorders, an update. Mol Genet Metab 2020;131:1-13. [PMID: 33129691 DOI: 10.1016/j.ymgme.2020.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Lee H, Kim Y, Lee I, Kim U, Baek J, Lee K. KL1333, a derivative of β-lapachone, protects against cisplatin-induced ototoxicity in mouse cochlear cultures. Biomedicine & Pharmacotherapy 2020;126:110068. [DOI: 10.1016/j.biopha.2020.110068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Coppi L, Ligorio S, Mitro N, Caruso D, De Fabiani E, Crestani M. PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism. Int J Mol Sci 2021;22:6913. [PMID: 34199142 DOI: 10.3390/ijms22136913] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Tinker RJ, Lim AZ, Stefanetti RJ, McFarland R. Current and Emerging Clinical Treatment in Mitochondrial Disease. Mol Diagn Ther 2021;25:181-206. [PMID: 33646563 DOI: 10.1007/s40291-020-00510-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Muszyński P, Bonda TA. Mitochondrial Dysfunction in Atrial Fibrillation-Mechanisms and Pharmacological Interventions. J Clin Med 2021;10:2385. [PMID: 34071563 DOI: 10.3390/jcm10112385] [Reference Citation Analysis]
12 Radelfahr F, Klopstock T. [Mitochondrial diseases]. Nervenarzt 2019;90:121-30. [PMID: 30643957 DOI: 10.1007/s00115-018-0666-2] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]